Anzeige
Mehr »
Login
Montag, 23.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Die erste börsennotierte Gesellschaft, die auf das gemeinsame Wachstum von Solana, XRP und Dogecoin setzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
522 Leser
Artikel bewerten:
(2)

Royal Philips: Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient care

Finanznachrichten News

January 25, 2021

  • Hospital will have access to Philips' latest technologies and informatics solutions to enhance the diagnosis, treatment, monitoring and management of patients
  • Multi-year strategic partnership will accelerate clinical research focused on image-guided minimally-invasive therapy, neurology, intensive care units and digital pathology

Amsterdam, the Netherlands -Royal Philips, one of France's leading hospitals in image-guided interventions, robotics and clinical research, today announced the signing of a 5-year technology and innovation partnership to support diagnostic, interventional imaging and patient monitoring and management, undertake clinical research, and leverage Philips' and Rennes University Hospital's ecosystems of open innovation to foster French start-up companies.

Philips will deliver new medical technologies and provide management and maintenance services for the hospital's diagnostic and interventional imaging modalities (MRI, CT, and image-guided therapy) as well as patient monitoring. Informatics solutions will offer central, high-resolution data capture and storage (data warehouses) to drive quality and efficiency improvements, and comprehensive visualization and analysis tools to enhance diagnostic confidence for complex medical cases. Philips Healthcare Transformation Services experts will help to optimize the hospital's clinical pathways and patient experience, especially for intensive care units (ICUs) and neuro-radiology departments.

"Philips and Rennes University Hospital are entering into a ground-breaking partnership aimed at significantly improving the stroke pathway and co-developing AI algorithms to improve care for the most acute patients, particularly those in the ICU," said David Corcos, General Manager Philips France. "Leveraging the hospital's clinical expertise and our respective innovation ecosystems, we believe we can jointly innovate to help the hospital's healthcare professionals improve care and outcomes for their patients, while contributing to a more sustainable healthcare system. We are thrilled by this unique opportunity."

Research and innovation
Key elements of the partnership are collaborative research and innovation activities focused on areas that combine Philips' technological expertise with Rennes University Hospital's clinical expertise. Co-development projects will focus on several key areas of joint strategic interest - optimized stroke management, robotics for neurological interventions, big data analytics and artificial intelligence (AI) for monitoring patients in ICUs, and AI algorithms to support digital pathology. In addition, the hospital will have access to Philips' in-house expertise and open-innovation ecosystem to foster the creation of French tech start-ups that can translate research into clinical solutions.

"The University Hospital of Rennes is particularly glad to join its forces with Philips in the framework of an original and ambitious partnership, unique in France, offering tremendous opportunities for innovation and co-development of new solutions to shape the future of medicine and patient care," said Véronique Anatole-Touzet, CEO at Rennes University Hospital. "This collaboration is the result of several years of fruitful collaboration. Thanks to its rich and integrated character, this partnership will be an amazing catalyst for innovation and research for the University Hospital of Rennes."

Rennes University Hospital, with more than 1,800 beds shared among 4 different sites, is one of the top 10 hospitals in France and a reference center in cardiac and vascular surgery, transplantation, next to other specialisms such as neurosurgery, neuroradiology and robotics. In terms of research and innovation, it has around 200 professionals involved in more than 1,700 research projects shared among 14 research units. Philips and Rennes University Hospital already have multiple collaborations in the field of medical imaging, plus an innovation partnership in digital pathology - the first of its kind in France. Today's strategic partnership also includes two associate partners of the University Hospital - the University of Rennes 1 and the Saint-Laurent polyclinic.

For further information, please contact:

Joost Maltha
Philips Global Press Office
Tel.: +31 6 10 55 81 16
E-mail: joost.maltha@philips.com

Elise Decenciere
Philips France media relations manager
Tel: +33 6 49 20 18 50
E-mail: elise.decenciere@philips.com

About Royal Philips

Royal Philips.

Attachment

  • Philips Azurion with Flexarm (https://ml-eu.globenewswire.com/Resource/Download/4dcfd805-4e10-4569-a3c5-a7eb540a3d31)

© 2021 GlobeNewswire (Europe)
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.